☆ 4.7 Editorial Material

Vitamin D and diabetes: the devil is in the D-tails

DIABETOLOGIA (2010)

Journal

DIABETOLOGIA

Volume 53, Issue 8, Pages 1545-1548

Publisher

SPRINGER

DOI: 10.1007/s00125-010-1791-z

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Nutrition & Dietetics

Vitamin D in Diabetes: Uncovering the Sunshine Hormone's Role in Glucose Metabolism and Beyond

Jie Wu, Annette Atkins, Michael Downes, Zong Wei

Summary: In recent decades, research has shown that vitamin D plays a significant role in the development of both type 1 and type 2 diabetes. Through the vitamin D receptor, it regulates insulin secretion and insulin sensitivity in various organs, improving glucose balance. Vitamin D deficiency, on the other hand, has been linked to increased incidence of both types of diabetes. Clinical trials have had conflicting results on whether vitamin D improves glycemia in type 2 diabetes, but meta-analyses suggest that raising serum vitamin D levels may reduce the progression from prediabetes to type 2 diabetes. This review summarizes current knowledge on the molecular mechanisms of vitamin D in insulin secretion, insulin sensitivity, and immunity, as well as the use of vitamin D as a treatment for diabetes in human studies.

NUTRIENTS (2023)

Add to Collection

Article Medical Laboratory Technology

Vitamin D in gestational diabetes: A broadened frontier

Yu Zhu, Ling Li, Ping Li

Summary: Vitamin D deficiency during pregnancy is common among women and can potentially affect the development and outcomes of gestational diabetes mellitus, but research results vary. Understanding the mechanisms of vitamin D deficiency on glucose metabolism and implementing vitamin D intervention are crucial for preventing and treating GDM.

CLINICA CHIMICA ACTA (2022)

Add to Collection

Editorial Material Physics, Multidisciplinary

The devil is in the defects

Arun Mannodi-Kanakkithodi

Summary: Calculations can predict the existence and properties of point defects in solids, but they often fail to capture the details accurately. A different method can greatly enhance the prediction of defect structures and properties.

NATURE PHYSICS (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Is Vitamin D Deficiency Related to Increased Cancer Risk in Patients with Type 2 Diabetes Mellitus?

Anna Gabryanczyk, Sylwia Klimczak, Izabela Szymczak-Pajor, Agnieszka Sliwinska

Summary: Vitamin D deficiency may contribute to increased cancer risk in T2DM patients by impacting factors such as insulin resistance and hyperglycemia. Vitamin D can reduce diabetes-driven cancer risk factors through mechanisms such as regulating DNA repair, cancer cell apoptosis, and signaling pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Editorial Material Biology

The devil is in the task structure

Orit Nafcha, Uri Hertz

Summary: Conflicting evidence on brain processing of social and individual learning arises from the type of information presented as the main source of knowledge in experiments.

ELIFE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Vitamin D and Beta Cells in Type 1 Diabetes: A Systematic Review

Josephine Yu, Preeti Sharma, Christian M. Girgis, Jenny E. Gunton

Summary: The prevalence of type 1 diabetes is rising steadily and vitamin D may contribute to this increase. This systematic review examined studies on vitamin D and type 1 diabetes, finding strong associations between low vitamin D levels and type 1 diabetes. Animal studies and human trials also suggest that vitamin D treatment or supplementation can be beneficial in reducing the risk of type 1 diabetes. Maintaining optimal circulating 25-hydroxyvitamin D levels may help to prevent or delay the development of type 1 diabetes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Genetics & Heredity

Vitamin D pathway gene polymorphisms, vitamin D level, and cytokines in children with type 1 diabetes

Watip Tangjittipokin, Pichakorn Umjai, Khwanhatai Khemaprasit, Parichat Charoentawornpanich, Chutima Chanprasert, Nipaporn Teerawattanapong, Tassanee Narkdontri, Jeerunda Santiprabhob

Summary: The study aimed to investigate genetic polymorphisms of vitamin D-related genes in children with T1D and their association with vitamin D and cytokine levels. Significant relationships were found between T1D and CYP2R1 polymorphism, as well as different VDR haplotypes between T1D patients and controls. Vitamin D gene-related variations were associated with vitamin D and circulating cytokine levels in children with T1D.

GENE (2021)

Add to Collection

Article Physics, Multidisciplinary

Is the Devil in h?

Andrei Khrennikov

Summary: This paper discusses the nonlocality of quantum mechanics and emphasizes the contradiction of the hidden variables model with Heisenberg's uncertainty and Bohr's complementarity principles.

ENTROPY (2021)

Add to Collection

Article Endocrinology & Metabolism

Vitamin D Status and All-Cause Mortality in Patients With Type 2 Diabetes in China

Yuxin Fan, Li Ding, Yalan Zhang, Hua Shu, Qing He, Jingqiu Cui, Gang Hu, Ming Liu

Summary: There is an association between vitamin D status and all-cause mortality among patients with type 2 diabetes. Very low or high concentrations of vitamin D may increase the risk of all-cause mortality in these patients.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Nutrition & Dietetics

Vitamin D Deficiency Is Significantly Associated with Retinopathy in Type 2 Diabetes Mellitus: A Case-Control Study

Jose M. Castillo-Oti, Ana I. Galvan-Manso, Maria R. Callejas-Herrero, Luis A. Vara-Gonzalez, Fernando Salas-Herrera, Pedro Munoz-Cacho

Summary: This study evaluated the association between vitamin D and diabetic retinopathy (DR) and determined the levels of vitamin D associated with a higher risk of DR. The results showed a significant relationship between levels of 25(OH)D and diabetes treatment with DR. Combining levels of 25(OH)D < 16 ng/mL and levels of 1,25(OH)2D < 29 pg/mL best predicted the risk of DR in relation to vitamin D deficiency. Insulin treatment was identified as a strong risk factor for DR.

NUTRIENTS (2022)

Add to Collection

Article Nutrition & Dietetics

Moderate Sun Exposure Is the Complementor in Insufficient Vitamin D Consumers

Shou-En Wu, Wei-Liang Chen

Summary: This study investigates the serum 25-hydroxy-vitamin D (25(OH)D) levels in healthy US civilians and identifies that sun exposure can compensate for low dietary vitamin D intake. Moderate sun exposure appears to be a simple and costless means for the public to increase their vitamin D levels.

FRONTIERS IN NUTRITION (2022)

Add to Collection

Article Environmental Sciences

Blood lead, vitamin D status, and albuminuria in patients with type 2 diabetes

Bin Wang, Heng Wan, Jing Cheng, Yingchao Chen, Yuying Wang, Yi Chen, Chi Chen, Wen Zhang, Fangzhen Xia, Ningjian Wang, Li Wang, Yingli Lu

Summary: Higher blood lead levels were associated with increased urinary albumin excretion in diabetic patients with vitamin D deficiency. However, this association was attenuated or non-significant in patients with sufficient vitamin D levels. The combination of high blood lead and low vitamin D levels corresponded to significantly higher urinary albumin-to-creatinine ratio. It was also found that the impact of blood lead levels on urinary albumin excretion was more pronounced in patients with reduced estimated glomerular filtration rate in the group with vitamin D deficiency.

ENVIRONMENTAL POLLUTION (2021)

Add to Collection

Article Nutrition & Dietetics

Vitamin D Status and Risk of Cystic Fibrosis-Related Diabetes: A Retrospective Single Center Cohort Study

Yiqing Peng, Malinda Wu, Jessica A. Alvarez, Vin Tangpricha

Summary: Cystic fibrosis-related diabetes (CFRD) affects up to half of CF patients by adulthood, primarily caused by pancreatic dysfunction. This study found that vitamin D deficiency increases the risk of developing CFRD in adults with CF, and maintaining a serum 25(OH)D concentration above 20 ng/mL may decrease this risk.

NUTRIENTS (2021)

Add to Collection

Article Endocrinology & Metabolism

Factors Defining the Association Between Vitamin D and Testosterone in Males With Type 2 Diabetes and Hypogonadism

Xin Hu, Xue Han, Yu Chen, Pingping Xiang, Xiao Wei, Tong Gong, Zhiwei He, Yafeng Su, Guofang Chen, Chao Liu

Summary: This study found that diabetic men with hypogonadism have lower levels of 25(OH)D compared to those without hypogonadism. There appears to be a positive association between serum 25(OH)D and testosterone levels, but this association may be influenced by age, duration, body mass index, and HbA1c.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Nutrition & Dietetics

Vitamin D Status and Gestational Diabetes in Russian Pregnant Women in the Period between 2012 and 2021: A Nested Case-Control Study

Aleksandra S. Tkachuk, Elena A. Vasukova, Anna D. Anopova, Tatiana L. Karonova, Evgenii A. Pustozerov, Yana A. Teplova, Angelina Eriskovskaya, Artem O. Isakov, Elena Y. Vasilieva, Maria A. Kokina, Irina Y. Zazerskaya, Tatiana M. Pervunina, Elena N. Grineva, Polina Popova

Summary: Several meta-analyses have found that low maternal serum 25-hydroxyvitamin D (25(OH)D) levels are associated with gestational diabetes mellitus (GDM). However, this study examined the association between serum 25(OH)D concentration and GDM in Russian women and found no significant correlation. Additionally, the increased intake of vitamin D supplements during pregnancy did not result in higher levels of 25(OH)D.

NUTRIENTS (2022)

Add to Collection

Article Endocrinology & Metabolism

Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia

Sara Charleer, Christophe De Block, Nancy Bolsens, Liesbeth Van Huffel, Frank Nobels, Chantal Mathieu, Pieter Gillard

Summary: This study investigates the impact of nationwide reimbursement of intermittently scanned continuous glucose monitoring (isCGM) on adults with type 1 diabetes with impaired or normal awareness of hypoglycemia over 24 months. The results show sustained improvement in severe hypoglycemia, work absenteeism, and hypoglycemia fear after isCGM reimbursement, with increased treatment satisfaction. isCGM is a valuable tool under long-term real-world conditions regardless of hypoglycemia awareness level.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Add to Collection

Letter Endocrinology & Metabolism

Women in diabetes research: we can do better. Reply to Bonnefond A [letter]

Chantal Mathieu, Stefano Del Prato

DIABETOLOGIA (2023)

Add to Collection

Review Endocrinology & Metabolism

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Tadej Battelino, Charles M. Alexander, Stephanie A. Amiel, Guillermo Arreaza-Rubin, Roy W. Beck, Richard M. Bergenstal, Bruce A. Buckingham, James Carroll, Antonio Ceriello, Elaine Chow, Pratik Choudhary, Kelly Close, Thomas Danne, Sanjoy Dutta, Robert Gabbay, Satish Garg, Julie Heverly, Irl B. Hirsch, Tina Kader, Julia Kenney, Boris Kovatchev, Lori Laffel, David Maahs, Chantal Mathieu, Didac Mauricio, Revital Nimri, Rimei Nishimura, Mauro Scharf, Stefano Del Prato, Eric Renard, Julio Rosenstock, Banshi Saboo, Kohjiro Ueki, Guillermo E. Umpierrez, Stuart A. Weinzimer, Moshe Phillip

Summary: Randomised controlled trials and other prospective clinical studies have traditionally used HbA1c as a measure of average blood glucose levels, but with the increasing use of continuous glucose monitoring (CGM), CGM-derived metrics are being considered for use in these studies. This consensus statement recommends the use of CGM data in clinical studies to provide additional clinical information beyond HbA1c. Standardizing the collection and reporting of CGM data in clinical trials can enhance the interpretability of the data and inform therapeutic decisions related to hypoglycaemia, postprandial hyperglycaemia, and glucose variability.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial

Margaretha M. Visser, Sara Charleer, Steffen Fieuws, Christophe De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Dirinck, Nele Myngheer, Chris Vercammen, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Pieter Gillard

Summary: The ALERTT1 study compared the benefits of switching from isCGM to rtCGM in adults with type 1 diabetes. The results showed that rtCGM improved glycemic control and reduced hypoglycemia worry significantly up to 24 months.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

The Belgian Diabetes in Pregnancy Follow-Up Study (BEDIP-FUS): A Multi-Centric Prospective Cohort Study on the Long-Term Metabolic Risk across Different Degrees of Gestational Glucose Intolerance: Methodology and Design

Lore Raets, Kim Van Hoorenbeeck, Toon Maes, Chris Vercammen, Christophe De Block, Eveline Dirinck, Inge Van Pottelbergh, Katrien Wierckx, Annouschka Laenen, Annick Bogaerts, Chantal Mathieu, Katrien Benhalima

Summary: The Belgian Diabetes in Pregnancy follow-up study (BEDIP-FUS) aims to investigate the impact of BMI, adiposity, and glucose intolerance on the metabolic profile and future risk for T2D in women and offspring after a five-year period. The study involves recruiting 375 women-offspring pairs based on the results of glucose challenge and oral glucose tolerance tests during pregnancy. The primary outcomes measured are glucose intolerance in mothers and BMI z-score in offspring. The study is important for individualizing follow-up care for women with different degrees of hyperglycemia during pregnancy and their offspring.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

Juan P. Frias, Srikanth Deenadayalan, Lars Erichsen, Filip K. Knop, Ildiko Lingvay, Stanislava Macura, Chantal Mathieu, Sue Pedersen, Melanie Davies

Summary: This study assessed the efficacy and safety of co-administered semaglutide with cagrilintide in participants with type 2 diabetes. The results showed that the combination treatment resulted in clinically relevant improvements in glycemic control and weight loss compared to cagrilintide alone, and it was well tolerated.

LANCET (2023)

Add to Collection

Article Medicine, General & Internal

Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin- treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, trial

Chantal Mathieu, Bjorg Asbjornsdottir, Harpreet S. Bajaj, Wendy Lane, Ana Laura S. A. Matos, Sreenivasa Murthy, Karolina Stachlewska, Julio Rosenstock

Summary: The ONWARDS 4 trial aimed to compare the efficacy and safety of once-weekly insulin icodec with once-daily insulin glargine U100 in individuals with long-standing type 2 diabetes. The results showed that icodec demonstrated similar improvements in glycaemic control compared to glargine U100, with fewer basal insulin injections and no increase in hypoglycaemic rates. The trial had limitations including its relatively short duration and open-label design.

LANCET (2023)

Add to Collection

Article Biology

High-Throughput Analysis of Neutrophil Extracellular Trap Levels in Subtypes of People with Type 1 Diabetes

Samal Bissenova, Mijke Buitinga, Markus Boesch, Hannelie Korf, Kristina Casteels, An Teunkens, Chantal Mathieu, Conny Gysemans

Summary: Neutrophils, an overlooked innate immune cell type, may play a crucial role in autoimmune diseases like type 1 diabetes. However, studying neutrophil function has been challenging due to disease heterogeneity and a lack of standardized methods. In this study, live-cell imaging was used to analyze neutrophil function and showed that neutrophils behave similarly in type 1 diabetes patients as healthy individuals. This suggests that neutrophils might contribute to autoimmune diseases through a mechanism called NET formation.

BIOLOGY-BASEL (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

Deirdre K. Tobias, Jordi Merino, Abrar Ahmad, Catherine Aiken, Jamie L. Benham, Dhanasekaran Bodhini, Amy L. Clark, Kevin Colclough, Rosa Corcoy, Sara J. Cromer, Daisy Duan, Jamie L. Felton, Ellen C. Francis, Pieter Gillard, Veronique Gingras, Romy Gaillard, Eram Haider, Alice Hughes, Jennifer M. Ikle, Laura M. Jacobsen, Anna R. Kahkoska, Jarno L. T. Kettunen, Raymond J. Kreienkamp, Lee-Ling Lim, Jonna M. E. Mannisto, Robert Massey, Niamh-Maire Mclennan, Rachel G. Miller, Mario Luca Morieri, Jasper Most, Rochelle N. Naylor, Bige Ozkan, Kashyap Amratlal Patel, Scott J. Pilla, Katsiaryna Prystupa, Sridharan Raghavan, Mary R. Rooney, Martin Schoen, Zhila Semnani-Azad, Magdalena Sevilla-Gonzalez, Pernille Svalastoga, Wubet Worku Takele, Claudia Ha-ting Tam, Anne Cathrine B. Thuesen, Mustafa Tosur, Amelia S. Wallace, Caroline C. Wang, Jessie J. Wong, Jennifer M. Yamamoto, Katherine Young, Chloe Amouyal, Mette K. Andersen, Maxine P. Bonham, Mingling Chen, Feifei Cheng, Tinashe Chikowore, Sian C. Chivers, Christoffer Clemmensen, Dana Dabelea, Adem Y. Dawed, Aaron J. Deutsch, Laura T. Dickens, Linda A. DiMeglio, Monika Dudenhoffer-Pfeifer, Carmella Evans-Molina, Maria Merce Fernandez-Balsells, Hugo Fitipaldi, Stephanie L. Fitzpatrick, Stephen E. Gitelman, Mark O. Goodarzi, Jessica A. Grieger, Marta Guasch-Ferre, Nahal Habibi, Torben Hansen, Chuiguo Huang, Arianna Harris-Kawano, Heba M. Ismail, Benjamin Hoag, Randi K. Johnson, Angus G. Jones, Robert W. Koivula, Aaron Leong, Gloria K. W. Leung, Ingrid M. Libman, Kai Liu, S. Alice Long, William L. Lowe, Robert W. Morton, Ayesha A. Motala, Suna Onengut-Gumuscu, James S. Pankow, Maleesa Pathirana, Sofia Pazmino, Dianna Perez, John R. Petrie, Camille E. Powe, Alejandra Quinteros, Rashmi Jain, Debashree Ray, Mathias Ried-Larsen, Zeb Saeed, Vanessa Santhakumar, Sarah Kanbour, Sudipa Sarkar, Gabriela S. F. Monaco, Denise M. Scholtens, Elizabeth Selvin, Wayne Huey-Herng Sheu, Cate Speake, Maggie A. Stanislawski, Nele Steenackers, Andrea K. Steck, Norbert Stefan, Julie Stoy, Rachael Taylor, Sok Cin Tye, Gebresilasea Gendisha Ukke, Marzhan Urazbayeva, Bart Van der Schueren, Camille Vatier, John M. Wentworth, Wesley Hannah, Sara L. White, Gechang Yu, Yingchai Zhang, Shao J. Zhou, Jacques Beltrand, Michel Polak, Ingvild Aukrust, Elisa de Franco, Sarah E. Flanagan, Kristin A. Maloney, Andrew McGovern, Janne Molnes, Mariam Nakabuye, Pal Rasmus Njolstad, Hugo Pomares-Millan, Michele Provenzano, Cecile Saint-Martin, Cuilin Zhang, Yeyi Zhu, Sungyoung Auh, Russell de Souza, Andrea J. Fawcett, Chandra Gruber, Eskedar Getie Mekonnen, Emily Mixter, Diana Sherifali, Robert H. Eckel, John J. Nolan, Louis H. Philipson, Rebecca J. Brown, Liana K. Billings, Kristen Boyle, Tina Costacou, John M. Dennis, Jose C. Florez, Anna L. Gloyn, Maria F. Gomez, Peter A. Gottlieb, Siri Atma W. Greeley, Kurt Griffin, Andrew T. Hattersley, Irl B. Hirsch, Marie-France Hivert, Korey K. Hood, Jami L. Josefson, Soo Heon Kwak, Lori M. Laffel, Siew S. Lim, Ruth J. F. Loos, Ronald C. W. Ma, Chantal Mathieu, Nestoras Mathioudakis, James B. Meigs, Shivani Misra, Viswanathan Mohan, Rinki Murphy, Richard Oram, Katharine R. Owen, Susan E. Ozanne, Ewan R. Pearson, Wei Perng, Toni I. Pollin, Rodica Pop-Busui, Richard E. Pratley, Leanne M. Redman, Maria J. Redondo, Rebecca M. Reynolds, Robert K. Semple, Jennifer L. Sherr, Emily K. Sims, Arianne Sweeting, Tiinamaija Tuomi, Miriam S. Udler, Kimberly K. Vesco, Tina Vilsboll, Robert Wagner, Stephen S. Rich, Paul W. Franks

Summary: Precision medicine, as part of contemporary evidence-based medicine, aims to reduce errors and optimize outcomes in medical decisions and health recommendations. This second international consensus report on precision diabetes medicine summarizes the findings from a systematic evidence review and highlights opportunities for clinical implementation as well as gaps in knowledge.

NATURE MEDICINE (2023)

Add to Collection

Article Endocrinology & Metabolism

Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development

Ylke Bruggeman, Pieter-Jan Martens, Gabriele Sassi, Marijke Viaene, Clive H. Wasserfall, Chantal Mathieu, Conny Gysemans

Summary: This study investigates the dynamics and phenotypes of immune cells infiltrating the pancreas and their changes in peripheral blood during the development of type 1 diabetes (T1D) in non-obese diabetic (NOD) mice. The early stages of T1D are characterized by an influx of dendritic cells and neutrophils in the pancreas. CD4+ and CD8+ T cells migrate from the pancreatic draining lymph nodes to the pancreas, coinciding with increased beta cell autoimmunity and insulitis severity. These findings provide important insights into the disease process and may contribute to the development of new therapies.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

Meeting Abstract Endocrinology & Metabolism

Prevalence of obesity in people living with type 1 diabetes across countries: an IMI2 SOPHIA analysis of data from Belgium, Kuwait, and Mexico

S. Pazmino, E. Al-Ozairi, A. Al Attar, J. Al Kandari, P. Alm-Eda-Valdes, N. Antonio-Villa, C. Delfin, R. Faradji, J. Rosen, J. Soderberg, T. Sparso, N. Steenackers, C. Mathieu, B. Van der Schueren, C. Le Roux

DIABETOLOGIA (2023)

Add to Collection

Meeting Abstract Endocrinology & Metabolism

Baseline HOMA2-B can predict tirzepatide efficacy: post hoc analysis of the SURPASS-1 and SURPASS-2 studies

J. Peleshok, S. H. Hsia, C. Mathieu, M. K. Thomas, H. Wang

DIABETOLOGIA (2023)

Add to Collection

Meeting Abstract Endocrinology & Metabolism

Glucometrics and glycaemic control in adults with type 1 diabetes when switching to insulin degludec

S. Charleer, R. De Groote, E. Lefever, P. Donne, C. De Block, C. Mathieu, P. Gillard

DIABETOLOGIA (2023)

Add to Collection

Meeting Abstract Endocrinology & Metabolism

Sustained improvement of glycaemic control and patient-reported outcomes after 12 months of advanced hybrid closed-loop in type 1 diabetes in real-world

J. De Meulemeester, M. M. Visser, B. Keymeulen, C. Vercammen, M. Strivay, G. Vanhaverbeke, C. De Block, L. Van Huffel, L. Winne, I. Lowyck, K. Spincemaille, R. Radermecker, D. Ballaux, C. Mathieu, P. Gillard

DIABETOLOGIA (2023)

Add to Collection

Review Medicine, Research & Experimental

Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review

Laura M. Jacobsen, Jennifer L. Sherr, Elizabeth Considine, Angela Chen, Sarah M. Peeling, Margo Hulsmans, Sara Charleer, Marzhan Urazbayeva, Mustafa Tosur, Selma Alamarie, Maria J. Redondo, Korey K. Hood, Peter A. Gottlieb, Pieter Gillard, Jessie J. Wong, Irl B. Hirsch, Richard E. Pratley, Lori M. Laffel, Chantal Mathieu, I ADA EASD PMD

Summary: Jacobsen, Sherr et al. evaluate the utility of novel technologies in the treatment of type 1 diabetes. Their systematic review finds technologies such as continuous glucose monitoring, insulin pumps, and decision support tools improve important measures (e.g., HbA1c, time in range, quality of life) allowing precision-directed uptake of technology.

COMMUNICATIONS MEDICINE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.